Cargando…
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor
BACKGROUND: Diabetes and its concurrent complications impact a significant proportion of the population of the US and create a large financial burden on the American health care system. FDA-approved maggot debridement therapy (MDT), the application of sterile laboratory-reared Lucilia sericata (gree...
Autores principales: | Linger, Rebecca J., Belikoff, Esther J., Yan, Ying, Li, Fang, Wantuch, Holly A., Fitzsimons, Helen L., Scott, Maxwell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804476/ https://www.ncbi.nlm.nih.gov/pubmed/27006073 http://dx.doi.org/10.1186/s12896-016-0263-z |
Ejemplares similares
-
Perception and Readiness to Undertake Maggot Debridement Therapy with the Use of Lucilia sericata Larvae in the Group of Nurses
por: Bazaliński, Dariusz, et al.
Publicado: (2022) -
Growth and Survival of Bagged Lucilia sericata Maggots in Wounds of Patients Undergoing Maggot Debridement Therapy
por: Čičková, Helena, et al.
Publicado: (2013) -
Effectiveness of Chronic Wound Debridement with the Use of Larvae of Lucilia Sericata
por: Bazaliński, Dariusz, et al.
Publicado: (2019) -
Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots
por: Franta, Zdeněk, et al.
Publicado: (2016) -
Beneficial effects of extracts from Lucilia sericata maggots on burn wounds in rats
por: Bian, Haixu, et al.
Publicado: (2017)